For the Inventor, By the Inventor

Enter assignee name

Grand Cayman, Cayman Islands

Xwpharma Ltd.

USPTO Granted Patents = 29

EPO Patents = 11

Trademarks = 1

Forward Citations = 13

Loading Chart...

Loading Chart...

26 inventors (with patents filed for the assignee):

Jia-Ning Xiang (15 out of 77 patents)

Jia-ning Xiang (13 out of 13 patents)

Daniel M Canafax (12 out of 13 patents)

4. William W Xiang (12 out of 12 patents)

5. Sami Karaborni (8 out of 30 patents)

6. James Tien (8 out of 8 patents)

7. Xuesong Xu (7 out of 19 patents)

8. Xianbo Liu (6 out of 8 patents)

9. Wai-Si Eng (6 out of 15 patents)

10. Hao-Wei Shih (5 out of 7 patents)

11. Zude Qi (4 out of 6 patents)

12. Dezheng Ning (4 out of 6 patents)

13. Xiaoming Wu (4 out of 4 patents)

14. Xuan Zhang (4 out of 9 patents)

15. Yi Feng (4 out of 7 patents)

Core Competencies:

Gamma-Hydroxybutyric Acid

Controlled Release

Pharmacokinetics

Ketamine Derivatives

4-Valyloxybutyric Acid

Neuronal Receptor Antagonists

Nuclear Transport Modulators

Reactive Oxygen Species

29 patents: Sort by Forward Citations

1. 12747199 - Crystalline 4-((L-valyl)oxy)butanoic acid (2026-09-29),

2. 12691090 - Pharmacokinetics of combined release formulations of a gamma-hydroxybutyric acid derivative (2026-07-28),

3. 12612357 - Methods of synthesizing 4-valyloxybutyric acid (2026-04-28),

4. 12396966 - Pharmaceutical compositions and oral dosage forms of ketamine derivatives (2025-08-26),

5. 12396956 - Modified release compositions of a gamma-hydroxybutyric acid derivative (2025-08-26),

6. 12337066 - Controlled release granulations of water-soluble active pharmaceutical ingredients (2025-06-24),

7. 12234226 - Compounds as nuclear transport modulators and uses thereof (2025-02-25),

8. 12209060 - Ketamine derivatives and compositions thereof (2025-01-28),

9. 12172980 - Compounds as neuronal histamine receptor-3 antagonists and uses thereof (2024-12-24),

10. 12030834 - Methods of synthesizing 4-valyloxybutyric acid (2024-07-09),

11. 11944597 - Pharmacokinetics of combined release formulations of a gamma-hydroxybutyric acid derivative (2024-04-02),

12. 11925710 - Modified release compositions of a GAMMA-hydroxybutyric acid derivative (2024-03-12),

13. 11905247 - Compounds as neurokinin-1 receptor antagonists and uses thereof (2024-02-20),

14. 11896573 - Pharmaceutical compositions and pharmacokinetics of a gamma-hydroxybutyric acid derivative (2024-02-13),

15. 11767313 - Compounds as nuclear transport modulators and uses thereof (2023-09-26),

Company Overview

Xwpharma Ltd. is a biotechnology company based in Grand Cayman, specializing in the development and commercialization of innovative therapeutic solutions. The organization focuses on advancing research in areas such as drug discovery and development, with an emphasis on addressing unmet medical needs. Xwpharma is committed to leveraging cutting-edge technologies and scientific expertise to create impactful treatments, contributing to the global healthcare landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

29 Patents

#30 in Grand Cayman

#40 in Cayman Islands

#22,570 in the World

Grand Cayman, Cayman Islands

Xwpharma Ltd.

Forward Citations = 13

26 inventors:

Jia-Ning Xiang (15 out of 77 patents)

Jia-ning Xiang (13 out of 13 patents)

Daniel M Canafax (12 out of 13 patents)

4. William W Xiang (12 out of 12 patents)

5. Sami Karaborni (8 out of 30 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Xwpharma Ltd.. Retrieved from https://idiyas.com/company/xwpharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…